Med Gom 10 by Grassomatic
Ruderalis × Indica × Sativa
Med Gom 1.0 by Grassomatic is a hybrid autoflowering strain developed in the early 2010s, aiming to provide accessible, balanced cannabinoid profiles for medicinal use. It was designed by the Spanish breeder Grassomatic to be user-friendly, finishing quickly from seed to harvest. This cultivar stands out for its approachability and its role in normalizing CBD-rich autoflowering options.
Appearance and Morphology
Med Gom 1.0 typically presents a compact plant structure, usually growing between 50-100 cm indoors. It features a prominent central cola with well-developed lateral branches, suitable for smaller cultivation spaces. The leaves exhibit hybrid characteristics, with medium-width blades. As it matures, the plant develops trichome-covered sugar leaves. Buds are moderately dense, offering good airflow and a reduced risk of mold, with calyxes that simplify trimming.
The plant's architecture is well-suited for indoor tents and stealthy setups. Yields are often in the range of 60-90 grams per plant indoors, with potential for 350-450 g/m² in optimized multi-plant environments. Outdoor cultivation can yield 70-120 grams per plant, particularly with larger containers.
Aroma and Flavor
The aroma of Med Gom 1.0 is generally subtle and herbal, with underlying notes of citrus and sweet hay. When handled, it can release scents reminiscent of lemon-lime, pine, and a mild floral lift, complemented by earthy undertones. This profile is less pungent than many diesel-forward strains, making it more discreet.
Flavors often mirror the aroma, presenting a blend of citrus, earth, and herbal notes. Some users detect hints of lavender and mango, contributing to a complex sensory experience that is both refreshing and grounding.
Effects
Med Gom 1.0 is noted for producing clear yet calm effects. Its balanced cannabinoid profile and terpene composition tend to promote a sense of relaxation without significant sedation. This makes it a suitable option for daytime use or for individuals seeking to manage stress.
The strain is often described as providing a gentle uplift that can help soothe the mind and body. Its effects are generally considered user-friendly, aligning with its development as a medicinal-forward cultivar.
Terpenes and Cannabinoids
While specific cannabinoid percentages can vary, Med Gom 1.0 is characterized by a balanced THC and CBD potential, with THC levels typically ranging from 15-25% and CBD below 1%. The terpene profile is often dominated by Myrcene, Limonene, and Caryophyllene. These terpenes contribute to the strain's aromatic qualities and potential effects.
Myrcene is associated with musky, herbal, and sometimes mango-like notes, while Limonene provides bright citrus aromas. Caryophyllene adds a peppery warmth. Other terpenes like Pinene and Linalool may also be present, contributing to the strain's overall sensory and therapeutic characteristics.
Growing Information
Med Gom 1.0 is an autoflowering hybrid, distinguished by its rapid growth cycle. It can typically be harvested within 60-70 days from germination, making it efficient for growers with limited time or space. Its ruderalis genetics ensure it flowers regardless of light cycle, allowing for consistent schedules like 18/6 or 20/4 from seed to harvest.
The plant is considered easy to grow, making it accessible for novice cultivators. It thrives in indoor environments, particularly in tents or smaller setups, and responds well to low-stress training. Yields are moderate, with a focus on consistent quality and manageable plant size.
Origins and Lineage
Developed by the Spanish breeder Grassomatic, Med Gom 1.0 emerged in the early 2010s as part of a movement to stabilize high-CBD autoflowering genetics. Its lineage is a three-way cross involving ruderalis, indica, and sativa genetics. The ruderalis component provides the autoflowering trait, while indica and sativa influences refine its characteristics.
Grassomatic aimed to create a medicinal-forward auto that was quick to finish and offered a balanced cannabinoid ratio. While specific parent strains are proprietary, the focus was on creating a stable, user-friendly plant that simplified access to CBD-rich cannabis for both home growers and medical consumers.